Some comments on frequently used multiple endpoint adjustment methods in clinical trials

Area of Science:

• Biostatistics
• Clinical Trial Design
• Statistical Inference

Background:

• Confirmatory clinical trials frequently utilize primary and secondary endpoints to assess treatment efficacy.
• Multiple primary endpoints necessitate statistical adjustments to prevent inflated Type I error rates.

Purpose of the Study:

• To discuss statistical challenges in clinical trials with multiple primary endpoints.
• To evaluate the performance of commonly used p-value adjustment procedures in controlling the Type I error rate.

Main Methods:

• Review of statistical concerns related to multiple endpoint adjustment procedures.
• Limited Monte Carlo simulations to assess the performance of selected p-value-based methods.

Main Results:

• P-value adjustment methods vary in their ability to protect the Type I error rate.
• Simulation results highlight the performance characteristics of different statistical approaches.

Conclusions:

• Careful selection and application of statistical adjustment methods are crucial for trials with multiple primary endpoints.
• Understanding the performance of these methods is essential for accurate interpretation of clinical trial results.